In the specialized field of molecular biology research, the SHP-2 activating peptide (specifically the IRS1_pY1172(dPEG8)pY1222 construct) serves as a vital tool for those investigating the complex conformational shifts of the SHP-2 phosphatase. My experience with these biochemical reagents has highlighted how specific phosphotyrosine- J Hu 著 · 2024 · 被引用数: 27 — The resultant activation of SHP2 by oleanolic acid suppresses Th17 differentiation and significantly alleviates colitis in mice. containing sequences are essential for modulating enzyme behavior M Marasco 著 · 2021 · 被引用数: 45 — They propose a mechanism of activation of SHP2 where the peptide binds to the closed conformation of the phosphatase, but only peptides binding to N-SH2 in in controlled experimental settings.
The Mechanism of SHP-2 Activation
The primary function of an SHP-2 activating peptide revolves around its ability to interact with the Src Homology 2 (SH2) domains of the SHP-2 enzyme. Research indicates that SHP-2 i J Hu 著 · 2024 · 被引用数: 27 — The resultant activation of SHP2 by oleanolic acid suppresses Th17 differentiation and significantly alleviates colitis in mice. s naturally maintained in a closed, autoinhibited conformation. The binding of a peptide—specifically a bisphosphorylated variant—to the N-SH2 domain is the key trigger. They propose a mechanism of activation of SHP2 where this binding event induces a structural rearrangement, effectively releasing the catalytic site and promoting the enzyme's phosphatase activity.
When we consider how SHP2 is activated by pY-peptides binding to the SH2 domains, it becomes clear why the precision of the sequence is paramou 2025 — 26 Peptides containing the sequence Tyr-X-X-Leu/Ile (about 10 amino acids) can specifically recognize the SH2 domain contained in the Src family nt. The phosphotyrosine couples peptide binding and SHP2 activation via an allosteric network. In my observations of these assays, the use of a bidentate peptide—which may contain both ITIM and ITSM motifs—often result NSC-13030 is a SHP2 inhibitor with an IC50 value of 3.2 μM. NSC-13030 reduces the proliferation and viability of breast cancer cells. NSC-13030 is applicable to s in a more robust response than mono-phosphorylated alternatives, as it facilitates a more stable interaction.
Experimental Considerations and Handling
For those working with the SHP-2 activating peptide in the lab, proper handling is non-negotiable to maintain the integrity of the molecule. Based on standard protocols:
* Solubility: The peptide is typically soluble in DMSO, which is the preferred solvent for maintaining stock concentrations before dilution into aqueous assay buffers.
* Storage: To prevent degradation, it is critical that the SHP2 Activating Peptide (IRS1_pY1172(dPEG8)pY1222) is stored at -20°C.
* Specificity: While peptides are highly effective, it is important to note t 2025/05/02 — In contrast to Ac-ITSM(pTyr), the C-SH2 targeting peptide 21 alone activated SHP2 only minimally at the highest peptide concentration. This hat certain structures, such as OP, activates SHP2 only weakly. This highlights the importance of selecting the co M Marasco 著 · 2020 · 被引用数: 299 — We demonstrate that a bidentate peptide, containing both ITIM and ITSM, activates SHP2 much more efficiently than either motif in isolation, rrect sequence for your specific experimental goal, whether you are studying SHP-2 signaling pathways or evaluating potential modulators.
Contextual Signaling and Interactions
The role of SHP-2 extends far beyond simple catalysis. Activation of SHP-2 and its association with Gab1 is a well-documented event that facilitates downstream signaling cascades, such as the RAS/ERK and PI3K/AKT pathways. SHP-2 leads to sustained RAS activation by dephosphorylating the RAS-GTPase-activating protein binding site on Gab1. Furthermore, SHPS-1 may play a crucial role both in the recruitment of SHP-2 from the cytosol to the plasma membrane, further increasing its catalytic potential in the cellular environment.
It is interesting to contrast this with inhibition studies. For instance, while we use peptides to study activating mechanisms, other molecules like NSC-13030 is a SHP2 inhibitor that functions with an IC50 of 3.2 μM. Distinguishing between these two modes of action—activating SHP2 vs. inhibiting it—is fundamental for anyone mapping out the complex protein-protein interaction networks involving this phosphatase.
Final Thoughts on Research Utility
Whether you are investigating the structural determinants of the N-SH2 domain or the kinetics of activated SHP2, the use of high-quality, synthetic peptides remains the gold standard. By utilizing a standardized SHP2 activating peptide, researchers can reliably replicate the allosteric shifts required to study the enzyme's function without relying on endogenous, variable stimuli. SHP2 is activated by binding of a phosphopeptide to the N-SH2 domain of SHP2, and mastering this interaction is the key to unlocking deeper insights into the regulation of this essential signaling protein.